Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria

被引:53
作者
Arkwright, Peter D. [1 ]
机构
[1] Univ Manchester, Booth Hall Childrens Hosp, Manchester, Lancs, England
关键词
RITUXIMAB;
D O I
10.1016/j.jaci.2008.11.043
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:510 / 511
页数:2
相关论文
共 5 条
[1]   Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency [J].
Alachkar, Hana ;
Taubenheim, Nadine ;
Haeney, Mansel R. ;
Durandy, Anne ;
Arkwright, Peter D. .
CLINICAL IMMUNOLOGY, 2006, 120 (03) :310-318
[2]   Off-label uses of rituximab in dermatology [J].
Carr, David R. ;
Heffernan, Michael P. .
DERMATOLOGIC THERAPY, 2007, 20 (04) :277-287
[3]   Treatment of chronic autoimmune urticaria with omalizumab [J].
Kaplan, Allen P. ;
Joseph, Kusumam ;
Maykut, Robert J. ;
Geba, Gregory P. ;
Zeldin, Robert K. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) :569-573
[4]   Lack of response of severe steroid-dependent chronic urticaria to rituximab [J].
Mallipeddi, R. ;
Grattan, C. E. H. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (03) :333-334
[5]  
Mease PJ, 2008, J RHEUMATOL, V35, P1245